WHO IT'S FOR

Who might
be interested
in VIMKUNYA?

Father and daughter exploring an outdoor market filled with baskets of fresh fruit, taking in the vibrant scenery around them

Anyone who spends time in an area where
chikungunya is present is at risk1:

  • Frequent travelers to areas where chikungunya is present1
  • Traveling families with children ages 12 and over2
  • Travelers ages 65 and over3
  • Travelers departing within the next 2 weeks to 6 months2,4,5
  • Travelers with pre-existing joint pain or certain medical
    conditions, like diabetes or cardiac disease3
See how to
administer vimkunya

Are you a
US healthcare professional?

Yes No

Indications and Usage

VIMKUNYA is a vaccine indicated for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older. The indication is approved under accelerated approval based on anti-chikungunya virus neutralizing antibody levels. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial.

Important Safety Information

Contraindications

Do not administer VIMKUNYA to individuals with a history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine.

Warnings and Precautions


Adverse Reactions

In clinical studies, the most common solicited adverse reactions (>10%) in individuals 12 through 64 years of age were pain at the injection site (23.7%), fatigue (19.9%), headache (18%), and myalgia (17.6%). The most commonly reported solicited adverse reactions (>5%) in individuals 65 years of age and older were injection site pain (5.4%), myalgia (6.3%), and fatigue (6.3%).

Use in Specific Populations

There are no clinical studies of VIMKUNYA in pregnant individuals.

To report SUSPECTED ADVERSE REACTIONS, contact Bavarian Nordic Inc. at
1-833-365-9596 or drug.safety@bavarian-nordic.com or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.

Please see full Prescribing Information here.

References

YOU ARE
NOW LEAVING VIMKUNYAHCP.COM

Continue Go back
plus orange
minus-orange.svg

Indications and Usage

VIMKUNYA is a vaccine indicated for the prevention of disease caused by chikungunya virus in individuals 12 years of age and older. The indication is approved under accelerated approval based on anti-chikungunya virus neutralizing antibody levels. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial.

Important Safety Information

Contraindications

Do not administer VIMKUNYA to individuals with a history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine.

Warnings and Precautions

  • Appropriate medical treatment must be immediately available to manage potential anaphylactic reactions.
  • Immunocompromised individuals, including individuals receiving immunosuppressive therapy, may have a diminished immune response to VIMKUNYA.
  • Syncope (fainting) may occur in association with administration of injectable vaccines including VIMKUNYA. Procedures should be in place to avoid injury from fainting.

Adverse Reactions

In clinical studies, the most common solicited adverse reactions (>10%) in individuals 12 through 64 years of age were pain at the injection site (23.7%), fatigue (19.9%), headache (18%), and myalgia (17.6%). The most commonly reported solicited adverse reactions (>5%) in individuals 65 years of age and older were injection site pain (5.4%), myalgia (6.3%), and fatigue (6.3%).

Use in Specific Populations

There are no clinical studies of VIMKUNYA in pregnant individuals.

To report SUSPECTED ADVERSE REACTIONS, contact Bavarian Nordic Inc. at
1-833-365-9596 or drug.safety@bavarian-nordic.com or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.

Please see full Prescribing Information here.

We use cookies on this site (and other similar technologies) to enhance your user experience.

You can manage your Privacy settings on our sites at any time

Decline Agree

Thank you for accepting cookies.

You can now hide this message or select MANAGE PRIVACY to edit your privacy permissions at any time.

Hide Manage Privacy

We use data collected by cookies and JavaScript libraries to improve your browsing experience, analyze site traffic, deliver personalized advertisements, and increase the overall performance of our sites.

You can manage your permissions for how we may use the data we collect using the settings below. These settings describe the current permissions we have enabled for you as a user of one of our sites. To change any permission, select YES to provide permission or NO to revoke or disallow permissions for any of the Categories or Purposes listed below.

For more information about how we handle personal information that you provide to us, you may access this site’s Privacy Policy at any time.

Allow Category Purpose Tools
Functional

To monitor the performance of our site and to enhance your browsing experience.

For example, these tools enable you to communicate with us via live chat.
Marketing and Analytics

To understand user behavior in order to provide you with a more relevant browsing experience or personalize the content on our site.

For example, we collect information about which pages you visit to help us present more relevant information.

 Google Analytics
Advertising

To personalize and measure the effectiveness of advertising on our site and other websites.

For example, we may serve you a personalized ad based on the pages you visit on our site.

 Facebook Pixel, Google Tag Manager
N/A Essential

We use browser cookies that are necessary for the site to work as intended.

For example, we store your website data collection preferences so we can honor them if you return to our site. You can disable these cookies in your browser settings but if you do the site may not work as intended.
You can also SUPPRESS or DELETE any information you've shared with us at any time.
CANCEL SAVE